These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 25693879)
1. Cost of acute stroke care for patients with atrial fibrillation compared with those in sinus rhythm. Ali AN; Howe J; Abdel-Hafiz A Pharmacoeconomics; 2015 May; 33(5):511-20. PubMed ID: 25693879 [TBL] [Abstract][Full Text] [Related]
2. The cost savings of newer oral anticoagulants in atrial fibrillation-related stroke prevention . Masbah N; Macleod MJ Int J Clin Pharmacol Ther; 2017 Mar; 55(3):220-230. PubMed ID: 28025962 [TBL] [Abstract][Full Text] [Related]
3. Incidence and cost of stroke and hemorrhage in patients diagnosed with atrial fibrillation in France. Cotté FE; Chaize G; Kachaner I; Gaudin AF; Vainchtock A; Durand-Zaleski I J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):e73-83. PubMed ID: 24119623 [TBL] [Abstract][Full Text] [Related]
4. The budget impact of left atrial appendage closure compared with adjusted-dose warfarin and dabigatran etexilate for stroke prevention in atrial fibrillation. Amorosi SL; Armstrong S; Da Deppo L; Garfield S; Stein K Europace; 2014 Aug; 16(8):1131-6. PubMed ID: 24687964 [TBL] [Abstract][Full Text] [Related]
5. Acute hospital, community, and indirect costs of stroke associated with atrial fibrillation: population-based study. Hannon N; Daly L; Murphy S; Smith S; Hayden D; Ní Chróinín D; Callaly E; Horgan G; Sheehan O; Honari B; Duggan J; Kyne L; Dolan E; Williams D; Wiley M; Kelly PJ Stroke; 2014 Dec; 45(12):3670-4. PubMed ID: 25358697 [TBL] [Abstract][Full Text] [Related]
6. Cost effectiveness of rivaroxaban for stroke prevention in German patients with atrial fibrillation. Mensch A; Stock S; Stollenwerk B; Müller D Pharmacoeconomics; 2015 Mar; 33(3):271-83. PubMed ID: 25404426 [TBL] [Abstract][Full Text] [Related]
7. Hospitalization expenses of acute ischemic stroke patients with atrial fibrillation relative to those with normal sinus rhythm. Li J; Luo W J Med Econ; 2017 Feb; 20(2):114-120. PubMed ID: 27559816 [TBL] [Abstract][Full Text] [Related]
8. The impact of atrial fibrillation on the cost of stroke: the berlin acute stroke study. Brüggenjürgen B; Rossnagel K; Roll S; Andersson FL; Selim D; Müller-Nordhorn J; Nolte CH; Jungehülsing GJ; Villringer A; Willich SN Value Health; 2007; 10(2):137-43. PubMed ID: 17391422 [TBL] [Abstract][Full Text] [Related]
9. The impact of ischaemic stroke on atrial fibrillation-related healthcare cost: a systematic review. Li X; Tse VC; Au-Doung LW; Wong ICK; Chan EW Europace; 2017 Jun; 19(6):937-947. PubMed ID: 27209573 [TBL] [Abstract][Full Text] [Related]
10. The costs of care in atrial fibrillation and the effect of treatment modalities in Germany. McBride D; Mattenklotz AM; Willich SN; Brüggenjürgen B Value Health; 2009; 12(2):293-301. PubMed ID: 18657103 [TBL] [Abstract][Full Text] [Related]
11. Societal Costs of First-Incident Ischemic Stroke in Patients with Atrial Fibrillation-A Danish Nationwide Registry Study. Jakobsen M; Kolodziejczyk C; Fredslund EK; Poulsen PB; Dybro L; Johnsen SP Value Health; 2016 Jun; 19(4):413-8. PubMed ID: 27325333 [TBL] [Abstract][Full Text] [Related]
12. Impact of atrial fibrillation on stroke-related healthcare costs. Sussman M; Menzin J; Lin I; Kwong WJ; Munsell M; Friedman M; Selim M J Am Heart Assoc; 2013 Nov; 2(6):e000479. PubMed ID: 24275631 [TBL] [Abstract][Full Text] [Related]
13. Are cost benefits of anticoagulation for stroke prevention in atrial fibrillation underestimated? Miller PS; Andersson FL; Kalra L Stroke; 2005 Feb; 36(2):360-6. PubMed ID: 15637326 [TBL] [Abstract][Full Text] [Related]
14. Review of economics and cost-effectiveness analyses of anticoagulant therapy for stroke prevention in atrial fibrillation in the US. von Schéele B; Fernandez M; Hogue SL; Kwong WJ Ann Pharmacother; 2013 May; 47(5):671-85. PubMed ID: 23606551 [TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of dabigatran versus vitamin K antagonists for the prevention of stroke in patients with atrial fibrillation: a French payer perspective. Chevalier J; Delaitre O; Hammès F; de Pouvourville G Arch Cardiovasc Dis; 2014; 107(6-7):381-90. PubMed ID: 24973113 [TBL] [Abstract][Full Text] [Related]
16. Comparing the economic burden of ischemic stroke patients with and without atrial fibrillation: a retrospective study in Beijing, China. Wen L; Wu J; Feng L; Yang L; Qian F Curr Med Res Opin; 2017 Oct; 33(10):1789-1794. PubMed ID: 28657348 [TBL] [Abstract][Full Text] [Related]
17. The effect of atrial fibrillation on stroke-related inpatient costs in Sweden: a 3-year analysis of registry incidence data from 2001. Ghatnekar O; Glader EL Value Health; 2008; 11(5):862-8. PubMed ID: 18489491 [TBL] [Abstract][Full Text] [Related]
18. Cost efficiency of anticoagulation with warfarin to prevent stroke in medicare beneficiaries with nonvalvular atrial fibrillation. Mercaldi CJ; Ciarametaro M; Hahn B; Chalissery G; Reynolds MW; Sander SD; Samsa GP; Matchar DB Stroke; 2011 Jan; 42(1):112-8. PubMed ID: 21148442 [TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of apixaban versus other new oral anticoagulants for stroke prevention in atrial fibrillation. Lip GY; Kongnakorn T; Phatak H; Kuznik A; Lanitis T; Liu LZ; Iloeje U; Hernandez L; Dorian P Clin Ther; 2014 Feb; 36(2):192-210.e20. PubMed ID: 24508420 [TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of rivaroxaban compared to warfarin for stroke prevention in atrial fibrillation. Lee S; Anglade MW; Pham D; Pisacane R; Kluger J; Coleman CI Am J Cardiol; 2012 Sep; 110(6):845-51. PubMed ID: 22651881 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]